| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: AMBI |
| Security Type |
Common Stock |
| Lead Underwriter |
Citi Leerink Swann & Co |
| Days In Registration |
84 |
| Date Filed |
20-Feb-2013 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Ambit Biosciences Corp, located in San Diego, California, is a biotechnology company engaged in discovering, developing and commercializing targeted small molecule therapeutics for the treatment of cancer. it also has an office located in Canada. The company was founded in 2000. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
14.58M |
| Contact |
- |
| Number of Employees |
30 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
1218.75K |
| File Amount |
$57.5M |
| File Price Range |
- - - |
| File Mid Price |
- |
Current Filing Information
(Amended 15-May-2013) |
|
US |
|
Shares Filed |
8.12M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
8.12M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$65.0M |
| · % Change from Original |
13.04 |
| File Price Range |
$8.00 - $8.00 |
| File Mid Price |
$8.00 |
|
